Jane Corbett Joins Vivante Health as Senior Vice President of Operations
Vivante Health, the leading digital solution for digestive health, proudly announced Jane Corbett has joined the company as Senior Vice President of Operations.
Read more
Craig Foster Joins Vivante Health as Senior Vice President of Commercial
Vivante Health, the leading digital solution for digestive health, proudly announced Craig Foster has joined the company as Senior Vice President of Commercial.
Vivante Health Expands Product Suite to Include the GIMate
Vivante Health, the leader in digital medicine for gut health and disease, proudly announces the GIMate, a first-of-its-kind handheld breath hydrogen monitor.
Vivante Health Welcomes Bruce Sands, MD, MS and Mark Pimental, MD to Scientific Advisory Board
Vivante Health, the leader in digital medicine for gut health and disease, proudly announced Simon Mathews, M.D. has joined the company as Chief Medical Officer.
Dan Anolik Joins Vivante Health as Chief Technology Officer
Vivante Health, the leader in digital medicine for gut health and disease, proudly announced Dan Anolik has joined the company as Chief Technology Officer.
Why Personalized Care Makes a Difference for Gut Health
Personalized care helps guide you towards goals/actions that fit in your life and will be effective at helping to relieve your symptoms. Here’s an inside look at our Care Team’s approach to personalized care.
Gastroenterologist Simon Mathews, MD Joins Vivante Health as Chief Medical Officer
Vivante Health, the leader in digital medicine for gut health and disease, proudly announced Simon Mathews, M.D. has joined the company as Chief Medical Officer.
Kimon Angelides, Vivante Health CEO, ‘Disrupts’ His Way to Top 50 in Digital Health
Dr. Kimon Angelides, Vivante Health founder and CEO, was named Disruptive Founder of the Year by the Top 50 in Digital Health committee.
Vivante Health Closes $5.8 Million Series A1 Investments
Houston, TX, January 20, 2020 – Vivante Health, the leader in digital medicine for gut health and disease, announced completion of its Series A1 investments this week after closing with healthcare investor Lifeforce Capital and tech-focused European investment firm, Big Pi Ventures, based in Athens. NFP Ventures, FCA Venture Partners, and Longmont Capital also participated…